Results 91 to 100 of about 2,327,467 (213)

The Predictive and Prognostic Value of the Systemic Immune-Inflammation Index for Congestive Heart Failure

Reviews in Cardiovascular Medicine
Background: The systemic immune-inflammatory index (SII), calculated by (platelet count × neutrophil count)/lymphocyte count, is a novel biomarker with predive and prognostic value in numerous diseases.
Zhihao Zheng, Shanshan Shi, Zechen Liu, Yanjun Song, Zhen’ge Chang, Kongyong Cui, Chenxi Song, Jia Li, Kefei Dou   +8 more
doaj   +1 more source

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases

, 2017
Interferon regulatory factors (IRFs) are evolutionarily conserved proteins expressed not only in immune cells but also in other tissues and organs outside the immune system.
Yaxing Zhang, Hongliang Li
core   +1 more source

Serum beta‐defensin‐2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI‐3 kinase and Rac1

JEADV Clinical Practice
Background Beta‐defensins (BDs) are antimicrobial peptides secreted upon epithelial injury. Both chemotactic and antimicrobial properties of BDs function as initial steps in host defence and prime the adaptive immune system in the body.
Carla J. Pantoja, Haiou Li, Justin Rodante, Andrew Keel, Alexander V. Sorokin, Axel Svedbom, Heather L. Teague, Mona Stahle, Nehal N. Mehta, Martin P. Playford   +9 more
doaj   +1 more source

HDL-associated vitamin D binding protein levels are inversely associated with necrotic plaque burden in psoriasis

Atherosclerosis Plus
Background and aims: Vitamin D binding protein (DBP) serves a dual function as a vitamin D carrier and actin scavenger. Free DBP is present in high concentrations in serum, while a smaller pool is bound to lipoproteins like HDL and VLDL.
M.P. Playford, H. Li, A.K. Dey, E.M. Florida, H.L. Teague, S.M. Gordon, N.N. Mehta   +6 more
doaj   +1 more source

Proportion of self-reported cardiometabolic diseases (CVD and diabetes) stratified by sociodemographic determinants.

Proportion of self-reported cardiometabolic diseases (CVD and diabetes) stratified by sociodemographic determinants.
Melissa Pirrie (6258230), Homa Keshavarz (18309655), Francine Marzanek (6258239), Gina Agarwal (3480008), Janice Lee (355107), Ricardo Angeles (6258236)   +5 more
core   +1 more source

Association Between Optimal Revascularization for Chronic Total Occlusion and Long‐Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The relationship between optimal revascularization for chronic total occlusion (CTO) lesions and long‐term clinical outcomes in patients with heart failure with or without type 2 diabetes (T2D) remains unclear.
Yanjun Song, Zhangyu Lin, Jining He, Rui Fu, Kefei Dou   +4 more
doaj   +1 more source

GWAS as a Driver of Gene Discovery in Cardiometabolic Diseases

, 2015
Cardiometabolic diseases represent a common complex disorder with a strong genetic component. Currently, genome-wide association studies (GWAS) have yielded some 755 single-nucleotide polymorphisms (SNPs) encompassing 366 independent loci that may help ...
Fu, Jingyuan, Wijmenga, Cisca, Fu, Jingyuan; id_orcid, Wijmenga, Cisca; id_orcid, Kumar, Vinod ; id_orcid, Atanasovska, Biljana, Hofker, Marten H., Kumar, Vinod   +7 more
core   +1 more source

Association of Triglyceride Glucose-Derived Indices with Recurrent Events Following Atherosclerotic Cardiovascular Disease

Journal of Obesity & Metabolic Syndrome
Background : Triglyceride glucose (TyG) and TyG-body mass index (TyG-BMI) are reliable surrogate indices of insulin resistance and used for risk stratification and outcome prediction in patients with atherosclerotic cardiovascular disease (ASCVD).
Sha Li, Hui-Hui Liu, Yan Zhang, Meng Zhang, Hui-Wen Zhang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Rui-Xia Xu, Qian Dong, Ke-Fei Dou, Jie Qian, Jian-Jun Li   +12 more
doaj   +1 more source

Prolonged dual antiplatelet therapy in invasively treated acute coronary syndrome patients with different lipoprotein(a) concentrations

Cardiology Journal
BACKGROUND: Lipoprotein(a) [Lp(a)] was positively associated with recurrent ischemic events in patients with acute coronary syndrome (ACS). This study was performed to investigate the effect of Lp(a) levels on outcomes of dual antiplatelet therapy (DAPT)
Kongyong Cui, Shaoyu Wu, Dong Yin, Weihua Song, Hongjian Wang, Chenggang Zhu, Lei Feng, Yuejin Yang, Rui Fu, Kefei Dou   +9 more
doaj   +1 more source

Prognostic role of lipoprotein(a) in atherosclerotic cardiovascular disease risk from a perspective on current risk stratification

MedComm
Lipoprotein(a) [Lp(a)] is an emerging predictor for atherosclerotic cardiovascular disease (ASCVD) but the association from a perspective on current risk stratification was unknown.
Sha Li, Hui‐Hui Liu, Yan Zhang, Meng Zhang, Hui‐Wen Zhang, Cheng‐Gang Zhu, Na‐Qiong Wu, Rui‐Xia Xu, Qian Dong, Jie Qian, Ke‐Fei Dou, Yuan‐Lin Guo, Jian‐Jun Li   +12 more
doaj   +1 more source